Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Steven D'Amato, RPH, BSPharm, on his team's strength as a result of the pandemic and habits to continue

Steven D'Amato, Executive Director, New England Cancer Specialists, on his team's strength as a result of the pandemic and habits to continue post pandemic

Tags: COA Conference CoveragePatient Care (includes Supportive Care, Palliative Care, Survivorship, QOL, Advocacy, Adverse Events, Pain Management)

Published: 04 May 2020

Recent Videos: COA Conference Coverage

video

Dinesh Kapur, MD, explains why his practice eventually decided to join OneOncology

Dr. Kapur, Hematology/Oncology, Eastern Connecticut Hematology & Oncology, explains why Eastern Connecticut Hematology & Oncology eventually decided to give up ...

video

Dinesh Kapur, MD, describes how OneOncology welcomed his group and impressive treatment resources

Dr. Kapur, Hematology/Oncology, Eastern Connecticut Hematology & Oncology, describes how OneOncology has welcomed his group and impressive cancer treatment resources

video

Dinesh Kapur, MD, provides thoughts on early impressions of CMMI and the Oncology Care First model

Dr. Kapur, Hematology/Oncology, Eastern Connecticut Hematology & Oncology, provides thoughts on early impressions of CMMI and the Oncology Care First ...

video

Dinesh Kapur, MD, shares thoughts on OCM reducing the cost of care and status of the quality

Dr. Kapur, Hematology/Oncology, Eastern Connecticut Hematology & Oncology, expresses thoughts on OCM reducing the cost of care and describes whether ...

video

Robert J. Brooks, MD, offers advantages and disadvantages of joining a large oncology group

Dr. Brooks, Medical Oncologist/Hematologist, Arizona Blood and Cancer Specialists, offers advantages and disadvantages of joining a large oncology group

video

Robert J. Brooks, MD, advises oncology practices that are considering whether to stay independent or to join a larger group of oncologists

Dr. Brooks, Medical Oncologist/Hematologist, Arizona Blood and Cancer Specialists, advises oncology practices that are considering whether to stay independent or ...

video

Robert J. Brooks, MD, describes how OneOncology has welcomed his group and impressive resources that help treat cancer patients

Dr. Brooks, Medical Oncologist/Hematologist, Arizona Blood and Cancer Specialists, describes how OneOncology has welcomed his group and impressive resources that ...

video

Stephen M. Schleicher, MD, provides examples of how aligning incentives has improved the quality of cancer care delivery while reducing the overall cost of care

Dr. Schleicher, Medical Oncologist, Tennessee Oncology, provides examples of how aligning incentives has improved the quality of cancer care delivery ...

video

Sibel Blau, MD, shares examples of applied informatics being incorporated into patient management

Dr. Blau, Medical Director, Northwest Medical Specialties, provides examples of how applied informatics are being incorporated into the management of ...

video

Sibel Blau, MD, on the improvement of care via AI, especially in high risk cancer patients

Dr. Blau, Medical Director, Northwest Medical Specialties, on how artificial intelligence is improving cancer care, especially in predicting high risk ...

Related Videos

video-image

Dinesh Kapur, MD, explains why his practice eventually decided to join OneOncology

video-image

Dinesh Kapur, MD, describes how OneOncology welcomed his group and impressive treatment resources

video-image

Dinesh Kapur, MD, provides thoughts on early impressions of CMMI and the Oncology Care First model

video-image

Dinesh Kapur, MD, shares thoughts on OCM reducing the cost of care and status of the quality

video-image

Robert J. Brooks, MD, offers advantages and disadvantages of joining a large oncology group

video-image

Robert J. Brooks, MD, advises oncology practices that are considering whether to stay independent or to join a larger group of oncologists

video-image

Robert J. Brooks, MD, describes how OneOncology has welcomed his group and impressive resources that help treat cancer patients

video-image

Stephen M. Schleicher, MD, provides examples of how aligning incentives has improved the quality of cancer care delivery while reducing the overall cost of care

video-image

Stephen M. Schleicher, MD, MBA, describes how the cost of drugs are impacting the effectiveness of APMs

video-image

Sibel Blau, MD, shares examples of applied informatics being incorporated into patient management

video-image

Sibel Blau, MD, on the improvement of care via AI, especially in high risk cancer patients

video-image

Sibel Blau, MD, expounds upon maintaining quality care with non-clinical staff working remotely

video-image

Kathy Oubre, describes robotic process automation and how it is helping with prior authorization

video-image

Kathy Oubre, details how creating tailored patient education has enhanced patient/provider relationships

video-image

Kathy Oubre, considers the predicted surge in cancer patients after the COVID-19 pandemic

video-image

Kathy Oubre, offers best practices and new programs being implemented to safely treat patients during the COVID-19 pandemic

video-image

Debra Patt, MD, on how applied informatics is being incorporated into cancer patient management

video-image

Debra Patt MD, expounds on the improvement of cancer care via artificial intelligence

video-image

Debra Patt, MD, offers opinion on whether embracing informatics is worth the financial investment

video-image

Jeffrey Patton, MD, expounds upon maintaining quality care with non-clinical staff working remotely

video-image

Jeffrey Patton, MD, anticipates whether smaller practices will be able to survive the pandemic or if they are in danger of closing due to lack of resources

video-image

Jeffrey Patton, MD, describes his care team's strengths during this pandemic and habits to continue post pandemic

video-image

Jeffrey Patton, MD, provides thoughts regarding the future of cancer care amidst a national crisis and providing quality cancer care across the country

video-image

Jeffrey Patton, MD, recalls barriers to overcome when treating patients with cancer during the COVID-19 pandemic

video-image

Steven D'Amato, RPH, BSPharm, on the adoption of telemedicine and its impact on the patient/provider relationship

video-image

Steven D'Amato, RPH, BSPharm, describes best practices and new programs being adopted to treat patients during the COVID-19 pandemic

video-image

Alti Rahman, MHA, MBA, on how robotic process automation aids with prior authorizations in his practice

video-image

Alti Rahman, MHA, MBA, offers an assessment of prior authorizations during the COVID-19 pandemic

video-image

Alti Rahman, MHA, MBA, explains the adoption of telemedicine and reimbursement expectations

video-image

Nick Recker, on the effectiveness of interoperability between telehealth platforms and oncology EMRs

video-image

Nick Recker, explains how successful oncology practices integrate telehealth beyond the COVID-19 pandemic

video-image

Nick Recker, shares issues facing practices as they rush to integrate telehealth into practice operations

video-image

Nick Recker, describes the role telehealth has played for healthcare providers during this current COVID-19 pandemic

video-image

Bo Gamble, describes the most common mistakes that practices make when coding for oncology treatment

video-image

Bo Gamble, expands on the practice coding problem and repercussions of improper coding

video-image

Bo Gamble, recommends best practices regarding proper coding for oncology practices

video-image

Bo Gamble, illustrates how practices are dealing with adding new CMS telehealth/telemedicine in the midst of the COVID-19 pandemic

video-image

Bo Gamble, shares concerns on the coding changes coming in 2021 and the impact impact they may have on community oncology

video-image

Antonio Ciaccia, expresses advantages Pharmacy Benefit Managers may bring to the healthcare system

video-image

Antonio Ciaccia, demonstrates how Pharmacy Benefit Managers are gaming the healthcare system

video-image

Antonio Ciaccia, explains how smaller pharmacies compete with PBMs and how they are being priced out

video-image

Antonio Ciaccia, on changes that need to be made on a national level that would bring Pharmacy Benefit Managers (PBMs) more in line with the interests of cancer patients and payers

video-image

Martin Dietrich, MD, PhD, provides thoughts on how socioeconomic factors affect on access to Comprehensive Genomic Profiling (CGP) tests and subsequent decision making

video-image

Martin Dietrich MD, PhD, offers resources to aid decision making after receiving Comprehensive Genomic Profiling tests results

video-image

Martin Dietrich, MD, shares concerns about the validity of Comprehensive Genomic Profiling tests and patient decision making

video-image

Martin Dietrich, MD, PhD, explains ordering Genomic Profiling (CPG) tests in the community oncology setting and the timeline of test results

video-image

Martin Dietrich, MD, PhD, describes a Comprehensive Genomic Profiling test, when it should be ordered, and information the test results provides

video-image

Kashyap Patel, MD, recalls his practice's adaption to OCM 1.0 and further adaption to OCM 2.0

video-image

Kashyap Patel, MD, updates us on the stance of OCM 2.0 as of the annual COA meeting 2020

video-image

Kashyap Patel, MD, provides examples of how aligning incentives has improved the quality of cancer care delivery while reducing the overall cost of care

video-image

Kashyap Patel, MD, expresses early impressions of CMMI and the Oncology Care First (OCF) model

video-image

Thomas Sonderberg, expresses opinion on components of care that are essential for employers to consider as part of their comprehensive coverage of their employees

video-image

Thomas Sonderberg, on the needs of small to midsize employers compared to larger employers with more contract leverage

video-image

Thomas Sonderberg, provides concerns of an employer coverage of cancer care and also the good news in cancer care

video-image

Thomas Sonderberg, describes the scope of cancer care cost to an employer and variations in coverage by types of employer

video-image

Kathy Oubre, on cancer patients being given home infusions of treatments during the COVID-19 pandemic

video-image

Stephen M. Schleicher, MD, MBA, on early impressions of CMMI and the Oncology Care First (OCF) model

video-image

Dinesh Kapur, MD, expresses changes in Eastern Connecticut Hematology Oncology amidst the COVID-19 pandemic

video-image

Sibel Blau, MD, describes her care team's strength while embracing new communications and technology in the midst of the COVID-19 pandemic

video-image

Steven D'Amato, RPh, BScPharm, on maintaining quality of care with non-clinical staff working remotely and the steps being taken to support this situation

video-image

Jeffrey Patton, MD, elaborates on critical success factors for providing quality cancer care during the COVID-19 pandemic

video-image

Debra Patt, MD, on how informatics work with physicians to aid in treatment decision making at the point of care

video-image

Thomas Sonderberg, describes challenges that employers face managing cancer care costs and the price of drugs

video-image

Bo Gamble, expounds on new services and associated codes that are important in the era of payment reform

video-image

Alti Rahman, MHA, MBA, shares examples of new practices being implemented to safely treat cancer patients through the COVID-19 pandemic

video-image

Nick Recker, comments on security issues related to rapid adoption of Telehealth in oncology practices

video-image

Antonio Ciaccia, describes pitfalls oncology practices need to know when prescribing a specialty cancer drug at a Pharmacy Benefit Managers-owned pharmacy

video-image

Martin Dietrich, MD, PhD, provides examples of how genetic profile tests are being used to make decisions on patient care

video-image

Kashyap Patel, MD, describes whether quality of care has suffered or improved as OCM reduces the cost of cancer care

video-image

Derek Raghavan, MD, examines the projected cost of new GNRH antagonist therapy and its implications

video-image

Marcia Brose, MD, PhD, provides opinion on who should be tested TRK fusions

video-image

Marcia Brose, MD, PhD, expounds on what should be done for patients who progress on larotrectinib

video-image

Marcia Brose, MD, PhD, on biopsy requirements for optimal evaluation for actionable TRK fusions

video-image

Marcia Brose, MD, PhD, describes how testing for TRK abnormalities are accomplished

video-image

Marcia Brose, MD, PhD, discusses the dosing, safety and efficacy of larotrectinib reported at ASCO20

video-image

Marcia Brose, MD, PhD, provides an overview of TRK fusion treatment in cancer patients

video-image

Daneng Li, MD, on the study results investigating the geriatric assessment tool & chemo side effects

video-image

Daneng Li, MD, describes the geriatric assessment tool developed at City of Hope

video-image

Bruce Feinberg DO, explains strategies that are or should be provided for managing cancer survivors

video-image

Bruce Feinberg, DO, provides examples of social determinants of health and how they qualify as this

video-image

Bruce Feinberg, DO, discusses the importance of social determinants to the health of cancer patients' outcomes

video-image

Sankalp Sethi & Jeffrey Patton, MD, on how pharma can help community oncology’s COVID-19 challenges

video-image

Sankalp Sethi and Jeffrey Vacirca, MD, FACP, examine partnering with pharma during COVID-19

video-image

Bruce Feinberg, DO, on the understanding medical oncologists have on social determinants of health